No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group.

Mitsune Tanimoto

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)97-104
Number of pages8
JournalInt J Hematol
Volume70
Issue number(2)
Publication statusPublished - 1999

Cite this

@article{14828547347440118ad7de6d2eecf447,
title = "No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group.",
author = "Mitsune Tanimoto",
year = "1999",
language = "English",
volume = "70",
pages = "97--104",
journal = "Int J Hematol",
number = "(2)",

}

TY - JOUR

T1 - No beneficial effect from addition of etoposide to daunorubicin, cytarabine, and 6-mercaptopurine in individualized induction therapy of adult acute myeloid leukemia: the JALSG-AML92 study. Japan Adult Leukemia Study Group.

AU - Tanimoto, Mitsune

PY - 1999

Y1 - 1999

M3 - Article

VL - 70

SP - 97

EP - 104

JO - Int J Hematol

JF - Int J Hematol

IS - (2)

ER -